ProKidney Corp. (PROK)
2.33
-0.01
(-0.43%)
USD |
NASDAQ |
Jan 12, 16:00
2.33
0.00 (0.00%)
After-Hours: 20:00
ProKidney Total Assets (Quarterly): 351.61M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | 89.64M |
| Nautilus Biotechnology, Inc. | 200.92M |
| Erasca, Inc. | 420.40M |
| Neumora Therapeutics, Inc. | 177.83M |
| CEL-SCI Corp. | 28.16M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 33.27M |
| Shareholders Equity (Quarterly) | -1.008B |
| Debt to Equity Ratio | -0.0042 |
| Current Ratio | 10.32 |
| Net Debt Paydown Yield | 0.15% |